Assess Recovery with Confidence: The Fugl-Meyer Assessment on BlueCloudX
The Fugl-Meyer Assessment (FMA) is a clinician-reported tool for evaluating motor recovery in post-stroke hemiplegia. Used globally in healthcare and research, it supports outcome measurement, treatment planning, and clinical trial endpoints. Paired with tools like the NIHSS and mRS, the FMA targets hemiplegia—affecting over 80% of stroke survivors.
Key Benefits
• Reliable, standardized evaluation
• Actionable recovery data
• Global regulatory recognition
• Supports informed care decisions
BlueCloudX simplifies FMA training and certification by delivering validated content, clinical evaluations, and digital certificates.
Sponsors gain real-time access to credentials, audit-ready documentation, and improved oversight—ensuring consistent administration, compliance, audit readiness and accelerated trial readiness.